Delivery Order SPE2DB20D2001-SPE2DB26FPLKW
- Not listed
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, valued at $2,720.90 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025, issued on September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $32,094.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectable medication, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 26, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,992.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on October 22, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $6,383.18 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen pharmaceutical supplies, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation...
- The Defense Logistics Agency awarded a $26,926.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. The contract, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be completed by October 28, 2025, with fulfillment occurring at...
- The Defense Logistics Agency awarded a $6,108.09 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a completion date of November 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $6,976.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on September 8, 2025, with completion targeted for September 9, 2025. This is a non-set-aside, competitively awarded contract with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB26FPLKWDelivery Order
The Defense Logistics Agency awarded a $6,048.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The underlying IDC functions as a global pharmaceutical support vehicle enabling the company to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Mounjaro, a diabetes management medication, reflects the company's ongoing role in supporting federal healthcare needs through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 10/31/25 |